J
Jade Biosciences, Inc. (JBIO)
NCM – Real vaqt narxi. Valyuta: USD
25.23
+0.37 (1.49%)
Yopilishda: May 12, 2026, 4:00 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NCM – Real vaqt narxi. Valyuta: USD
25.23
+0.37 (1.49%)
Yopilishda: May 12, 2026, 4:00 PM EDT
Jade Biosciences, Inc. yallanish va immunologiya ko'rsatkichlari uchun davolash usullarini ishlab chiqadigan biotexnologiya kompaniyasi sifatida faoliyat yuritadi, ayniqsa autoimmün kasalliklari bilan kasallangan bemorlarda. Kompaniya JADE101ni ishlab chiqmoqda, bu A PRoliferation Inducing Ligand oqsilini blokirovka qilish uchun mo'ljallangan monoklonal antidir, u 1-faza klinik sinovlarida. Kompaniya, shuningdek, preklinik rivojlanish bosqichida bo'lgan JADE201 va JADE-003ni ishlab chiqmoqda. Jade Biosciences, Inc. Paragon Therapeutics, Inc. bilan hamkorlik shartnomasiga ega. Jade Biosciences, Inc. Uoltem, Massachusetsda joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Edward R. Conner M.D. | Chief Medical Officer |
| Dr. Jason Wright Ph.D. | Senior Vice President of Chemistry, Manufacturing & Controls |
| Mr. Bradford D. Dahms Ph.D. | CFO & Treasurer |
| Mr. Jonathan Quick | Senior Vice President of Finance |
| Mr. Tom Frohlich | President, CEO & Director |
| Ms. Amy Sullivan | Senior Vice President of Development Operations |
| Ms. Sandy Lewis | Senior Vice President, Biometrics & Clinical Strategy |
| Ms. Valerie Fauvelle | Senior Vice President of Regulatory & Quality |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-05-07 | S-8 | d61004ds8.htm |
| 2026-04-28 | DEFA14A | d116556ddefa14a.htm |
| 2026-04-28 | DEF 14A | d52810ddef14a.htm |
| 2026-04-22 | 8-K | d90643d8k.htm |
| 2026-04-17 | PRE 14A | d52810dpre14a.htm |
| 2026-04-02 | 8-K | d147217d8k.htm |
| 2026-03-06 | 10-K | ck0001798749-20251231.htm |
| 2026-01-05 | 8-K | d93206d8k.htm |
| 2025-12-23 | CORRESP | filename1.htm |
| 2025-12-22 | S-1 | d19711ds1.htm |